End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
01 1MELOXICAM
02 1VERSACLOZ
01 121530
02 1203479
01 1No
02 1Yes
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Drug : VERSACLOZ
Dosage Form : SUSPENSION; ORAL
Application Number : 203479
Country : US
Patented : Yes
Drug : MELOXICAM
Dosage Form : SUSPENSION; ORAL
Application Number : 21530
Country : US
Patented : No
